Nu-Med Plus, Inc. Net Income Loss

Quick Answer

Nu-Med Plus, Inc. reported Net Income Loss of -$68.3 thousand for the year ending 2024.

  • Nu-Med Plus, Inc. showed an increase of +45.6% in Net Income Loss from 2023 to 2024.
  • This data is from Nu-Med Plus, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2012 to 2024 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2013: -$82.7 thousand | Q2 2013: -$36.7 thousand | Q3 2013: -$142.1 thousand | Q1 2014: -$213.6 thousand | Q2 2014: -$202.3 thousand | Q3 2014: -$242.9 thousand | Q1 2015: -$122.6 thousand | Q2 2015: -$393.3 thousand | Q3 2015: -$307.4 thousand | Q1 2016: $10.97 million | Q2 2016: -$228.0 thousand | Q3 2016: -$772.2 thousand | Q1 2017: $3.99 million | Q2 2017: -$116.1 thousand | Q3 2017: -$143.0 thousand | Q1 2018: -$147.5 thousand | Q2 2018: -$173.6 thousand | Q3 2018: -$526.8 thousand | Q1 2019: -$428.2 thousand | Q2 2019: -$248.2 thousand | Q3 2019: -$150.6 thousand | Q1 2020: -$153.3 thousand | Q2 2020: -$908.5 thousand | Q3 2020: -$453.8 thousand | Q1 2021: -$356.7 thousand | Q2 2021: -$242.6 thousand | Q3 2021: -$118.4 thousand | Q1 2022: -$56.7 thousand | Q2 2022: -$58.1 thousand | Q3 2022: -$58.1 thousand | Q1 2023: -$28.2 thousand | Q2 2023: -$24.3 thousand | Q3 2023: -$16.4 thousand | Q1 2024: -$21.8 thousand | Q2 2024: -$17.3 thousand | Q3 2024: -$18.7 thousand | Q1 2025: -$19.9 thousand | Q2 2025: -$11.7 thousand | Q3 2025: -$12.0 thousand.
  • Over the full 13 years of available data (2012 to 2024), Nu-Med Plus, Inc.'s Net Income Loss has grown by 74.0%.
  • Historical annual values: Fiscal year 2024: -$68.3 thousand | Fiscal year 2023: -$125.5 thousand | Fiscal year 2022: -$130.2 thousand | Fiscal year 2021: -$830.1 thousand | Fiscal year 2020: -$2.01 million | Fiscal year 2019: -$1.04 million | Fiscal year 2018: -$1.19 million | Fiscal year 2017: $3.58 million | Fiscal year 2016: $9.65 million | Fiscal year 2015: -$8.88 million | Fiscal year 2014: -$1.19 million | Fiscal year 2013: -$332.3 thousand | Fiscal year 2012: -$262.7 thousand.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: